Hepatobiliary disease in XLMTM: a common comorbidity with potential impact on treatment strategies
Authors:
Open Access
- 12 October 2021
- journal article
- research article
- Published by Springer Nature in Orphanet Journal of Rare Diseases
- Vol. 16 (1) , 1-7
Abstract
Background: X-linked myotubular myopathy (XLMTM) is a rare congenital myopathy resulting from pathogenic variants in the MTM1 gene. Affected male subjects typically present with severe hypotonia and respiratory distress at birth and they often require intensive supportive care. Long-term survivors are often non-ambulant, ventilator and feeding tube–dependent and they generally show additional organ manifestations, indicating that myotubularin does play a vital role in tissues other than muscle. For XLMTM several therapeutic strategies are under investigation. For XLMTM several therapeutic strategies are under investigation including a study of intravenous MTM1 gene transfer using a recombinant AAV8 vector of which has some concerns arises due to hepatotoxicity. Results: We report prospective and retrospective clinical data of 12 XLMTM patients collected over a period of up to 10 years. In particular, we carried out a thorough review of the data about incidence and the course of hepatobiliary disease in our case series. Conclusions: We demonstrate that hepatobiliary disease represents a common comorbidity of XLMTM that seems irrespective to age and diseases severity. We recommend to carefully explore and monitor the hepatobiliary function in XLMTM patients. We believe that a better understanding of the pathogenic mechanisms that induce hepatobiliary damage is essential to understand the fatal events that may occur in the gene therapy program.Keywords
All Related Versions
Funding Information
- Valerion Therapeutics
- Genethon
This publication has 26 references indexed in Scilit:
- Defective Membrane Remodeling in Neuromuscular Diseases: Insights from Animal ModelsPLOS Genetics, 2012
- Modeling the human MTM1 p.R69C mutation in murine Mtm1 results in exon 4 skipping and a less severe myotubular myopathy phenotypeHuman Molecular Genetics, 2011
- Myotubularin controls desmin intermediate filament architecture and mitochondrial dynamics in human and mouse skeletal muscleJournal of Clinical Investigation, 2011
- T-tubule biogenesis and triad formation in skeletal muscle and implication in human diseasesSkeletal Muscle, 2011
- Welcome to Skeletal MuscleSkeletal Muscle, 2011
- T-tubule disorganization and defective excitation-contraction coupling in muscle fibers lacking myotubularin lipid phosphataseProceedings of the National Academy of Sciences, 2009
- Loss of Myotubularin Function Results in T-Tubule Disorganization in Zebrafish and Human Myotubular MyopathyPLOS Genetics, 2009
- AAV-mediated intramuscular delivery of myotubularin corrects the myotubular myopathy phenotype in targeted murine muscle and suggests a function in plasma membrane homeostasisHuman Molecular Genetics, 2008
- Myotubularin Regulates the Function of the Late Endosome through the GRAM Domain-Phosphatidylinositol 3,5-Bisphosphate InteractionJournal of Biological Chemistry, 2004
- Genotype–phenotype correlations in X-linked myotubular myopathyNeuromuscular Disorders, 2002